Clinical trials: Hypohidrosis

Fabry Disease

Dosing Study of Replagal in Patients With Fabry Disease

• Completed
• Age: All ages
• Phase 2
• Results posted

This study will determine the safety and effectiveness of increasing Replagal infusions in certain patients with Fabry disease. Replagal is a genetically engineered form of Alpha-galactosidase A, an enzyme that normally breaks…

Trial name

NCT00068107

Testing

Replagal

Where

United States

Volunteers

13 people

Sponsor

Baylor Research Institute